Sodium pyruvate treatment for hyperkeratotic disorders.
Publication
, Journal Article
Levy, SB; Goldsmith, LA
Published in: South Med J
March 1979
We have successfully used 5% sodium pyruvate in Eucerin for the treatment of congenital disorders with hyperkeratosis. It was most effective in those disorders with the most hyperkeratosis, and it was nonirritating even after extensive use. The efficacy of pyruvate may be due to the relatively low pKa of pyruvic acid.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
South Med J
DOI
ISSN
0038-4348
Publication Date
March 1979
Volume
72
Issue
3
Start / End Page
307 / 310
Location
United States
Related Subject Headings
- Xipamide
- Pyruvates
- Middle Aged
- Male
- Keratosis
- Keratolytic Agents
- Humans
- General & Internal Medicine
- Female
- Dermatologic Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Levy, S. B., & Goldsmith, L. A. (1979). Sodium pyruvate treatment for hyperkeratotic disorders. South Med J, 72(3), 307–310. https://doi.org/10.1097/00007611-197903000-00022
Levy, S. B., and L. A. Goldsmith. “Sodium pyruvate treatment for hyperkeratotic disorders.” South Med J 72, no. 3 (March 1979): 307–10. https://doi.org/10.1097/00007611-197903000-00022.
Levy SB, Goldsmith LA. Sodium pyruvate treatment for hyperkeratotic disorders. South Med J. 1979 Mar;72(3):307–10.
Levy, S. B., and L. A. Goldsmith. “Sodium pyruvate treatment for hyperkeratotic disorders.” South Med J, vol. 72, no. 3, Mar. 1979, pp. 307–10. Pubmed, doi:10.1097/00007611-197903000-00022.
Levy SB, Goldsmith LA. Sodium pyruvate treatment for hyperkeratotic disorders. South Med J. 1979 Mar;72(3):307–310.
Published In
South Med J
DOI
ISSN
0038-4348
Publication Date
March 1979
Volume
72
Issue
3
Start / End Page
307 / 310
Location
United States
Related Subject Headings
- Xipamide
- Pyruvates
- Middle Aged
- Male
- Keratosis
- Keratolytic Agents
- Humans
- General & Internal Medicine
- Female
- Dermatologic Agents